607 filings
Page 6 of 31
UPLOAD
7wqtcb5nay0 42wt7ws
2 Nov 20
Letter from SEC
12:00am
PRER14A
f56kexn7m2ex
30 Oct 20
Preliminary revised proxy
11:18am
EFFECT
ljfzr
29 Oct 20
Notice of effectiveness
12:15am
424B3
f9at14s 62
28 Oct 20
Prospectus supplement
5:18pm
UPLOAD
84xhf olbwr94olw63j3
28 Oct 20
Letter from SEC
12:00am
CORRESP
beiinrv467rq
28 Oct 20
Correspondence with SEC
12:00am
CORRESP
t05y9
26 Oct 20
Correspondence with SEC
12:00am
UPLOAD
r1gbkgd0fcon17pm h4
16 Oct 20
Letter from SEC
12:00am
8-K
ja3jc r8tc4
5 Oct 20
Entry into a Material Definitive Agreement
4:05pm
8-K
cll8yd5zj1v0nfi
25 Sep 20
RespireRx Pharmaceuticals Inc. Announces Appointment of David Dickason as Senior Vice President Pre-Clinical Product Development
5:16pm
S-8
t0mdeeu0li
15 Sep 20
Registration of securities for employees
4:21pm
NT 10-Q
1ulnh34p
14 Aug 20
Notice of late quarterly filing
10:50am
D
ujmd487d hl2r
12 Aug 20
$193.25K in debt / options / securities to be acquired, sold $193.25K, 2 investors
1:13pm
D
61789ja7q6aoq qv5p
12 Aug 20
$2M in equity / debt, 1 investor
12:30pm
8-K
kogzlhaz
5 Aug 20
Patent License Agreement
12:00am